TP53 and adrenal cortex carcinoma: According to genomic analyses, germline mutations in TP53 were observed in 50–80% of children with sporadic ACC, while somatic TP53 mutation was observed in 20% to 30% of sporadic ACC patients where it correlates with poor outcome [27].